← Evidence map

ArticleJAMA ophthalmology2019

Recognizing the True Cost of Medical Spending-An Assessment of Ranibizumab for Retinal Disorders.

Steven M Kymes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31647498